Published in J Natl Cancer Inst on October 01, 1982
Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest (1989) 1.38
Protective effect of biological response modifiers on murine cytomegalovirus infection. J Virol (1984) 1.10
New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases. Cancer Chemother Pharmacol (1994) 0.77
Involvement of cell surface macromolecules sensitive to alkylating ketones in lysis by human peripheral blood NK cells. Clin Exp Immunol (1985) 0.75
Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells. Br J Cancer (1983) 0.75
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity (1999) 12.36
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science (2001) 8.31
Structure and expression of a cloned cDNA for human interleukin-2. Nature (1983) 7.04
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell (2000) 6.71
Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci U S A (1995) 4.31
Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets. J Immunol (1983) 4.25
Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet (1997) 4.19
Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol (1998) 4.14
Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med (1988) 3.50
Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci U S A (1999) 3.43
TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol (1985) 3.18
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem (2000) 3.15
NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J (2001) 2.94
Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol (2001) 2.75
Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol (1991) 2.71
Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg (1987) 2.69
ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J (1989) 2.62
Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer (1988) 2.46
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. J Clin Invest (1983) 2.32
On the heterogeneity of murine natural killer cells. J Exp Med (1981) 2.15
Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation (1995) 2.15
Unique structure of murine interleukin-2 as deduced from cloned cDNAs. Nature (1985) 2.15
Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol Cell Biol (2000) 2.14
Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem (1994) 2.02
Visualization of the attachment organelle and cytadherence proteins of Mycoplasma pneumoniae by immunofluorescence microscopy. J Bacteriol (2001) 1.95
The bHLH gene Hes1 is essential for expansion of early T cell precursors. Genes Dev (1999) 1.95
Early gastric cancer. Endoscopic diagnosis of depth of invasion. Dig Dis Sci (1990) 1.94
Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion. J Biol Chem (1999) 1.86
Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor. J Immunol (1983) 1.84
Small "flat adenoma" of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum (1985) 1.82
Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med (1979) 1.81
Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci U S A (1990) 1.72
Diverticular disease of the colon in Japan. A review of 615 cases. Dis Colon Rectum (1984) 1.70
Developmentally regulated expression of the PD-1 protein on the surface of double-negative (CD4-CD8-) thymocytes. Int Immunol (1996) 1.68
Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc Natl Acad Sci U S A (1998) 1.66
Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect Immun (1993) 1.64
Mode of regulation of natural killer cell activity by interferon. J Exp Med (1980) 1.63
Radioisotopic studies on renewal of opsin. Vision Res (1968) 1.63
Gastric syphilis: polymerase chain reaction detection of treponemal DNA in pseudolymphomatous lesions. Hum Pathol (1996) 1.63
Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon. J Clin Invest (1986) 1.60
Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens. J Immunol (2001) 1.59
Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J Biol Chem (2000) 1.59
Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) sing. Nature (1969) 1.58
Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer (1990) 1.58
Postoperative recurrence of hepatocellular carcinoma. Ann Surg (1990) 1.55
FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem (1999) 1.55
Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2. Segregate expression profiles from a rap1GAP gene product. J Biol Chem (1997) 1.54
Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res (1970) 1.54
Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res (2001) 1.53
Relationships between perceived workload, stress and oxidative DNA damage. Int Arch Occup Environ Health (2001) 1.51
Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood (1991) 1.51
The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J Biol Chem (2001) 1.50
Solitary rectal ulcer syndrome accompanied by submucosal invasive carcinoma. Am J Gastroenterol (1998) 1.50
Cytophagic histiocytic panniculitis improved by combined CHOP and cyclosporin A treatment. Intern Med (1999) 1.49
Anti-cathepsin G antibodies in the sera of patients with ulcerative colitis. J Gastroenterol (2000) 1.49
Clock gene dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J (2008) 1.49
A technique for complete thymectomy in adult rats. J Immunol Methods (1994) 1.47
Sjögren's syndrome with primary biliary cirrhosis, complicated by transverse myelitis and malignant lymphoma. Intern Med (2000) 1.44
Abundant expression of common cytokine receptor gamma chain (CD132) in rheumatoid joints. J Rheumatol (2001) 1.44
4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem (1999) 1.44
Comparison of coronary responses to intracoronary and intraaortic ergonovine and isosorbide dinitrate in patients with atypical chest pain. Am J Cardiol (1992) 1.43
Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology (1996) 1.43
Analysis of peripheral blood mononuclear cell stimulated with pyruvate dehydrogenase complex, T-cell receptors from patients with primary biliary cirrhosis. J Gastroenterol (1998) 1.41
Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci (1991) 1.39
Takayasu's arteritis in a 69 year-old woman. Intern Med (2000) 1.38
Increased tumor establishment and growth after laparotomy vs laparoscopy. Arch Surg (1996) 1.38
Guideline of surgical management based on diffusion of descending necrotizing mediastinitis. Jpn J Thorac Cardiovasc Surg (1999) 1.35
Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch A Pathol Anat Histopathol (1992) 1.35
Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. Proc Natl Acad Sci U S A (1981) 1.34
B cell growth factor and T cell growth factor produced by mitogen-stimulated normal human peripheral blood T lymphocytes are distinct molecules. J Immunol (1982) 1.33
Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen. J Immunol (2001) 1.32
Facilitation of beta selection and modification of positive selection in the thymus of PD-1-deficient mice. J Exp Med (2000) 1.32
Molecular analysis of the interleukin-2 system. Immunol Rev (1986) 1.32
The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPMI8226 cells. J Biochem (1997) 1.29
Lymphatic and local spread of T1 and T2 pancreatic cancer. A study of autopsy material. Ann Surg (1986) 1.27
A sensitive enzyme-linked immunosorbent assay for human interleukin-8. J Immunol Methods (1992) 1.26
Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. Proc Natl Acad Sci U S A (1987) 1.25
Cloning and sequencing of the Sphingomonas (Pseudomonas) paucimobilis gene essential for the O demethylation of vanillate and syringate. Appl Environ Microbiol (1998) 1.25
IL-7 promotes thymocyte proliferation and maintains immunocompetent thymocytes bearing alpha beta or gamma delta T-cell receptors in vitro: synergism with IL-2. J Immunol (1989) 1.24
Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression. Mol Cell Biol (1995) 1.24
Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol Chem (1996) 1.24
CD3+4-8- alpha beta T cell population with biased T cell receptor V gene usage. Presence in bone marrow and possible involvement of IL-3 for their extrathymic development. J Immunol (1992) 1.22
Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation. J Immunol (1986) 1.22
Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones. J Immunol (1985) 1.22
IL 2 receptor induction on human T lymphocytes: role for IL 2 and monocytes. J Immunol (1985) 1.22
Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor. Infect Immun (1994) 1.22
Characterization of a neu/c-erbB-2 protein-specific activating factor. Proc Natl Acad Sci U S A (1991) 1.21
Stimulation and priming of human neutrophils by interleukin-8: cooperation with tumor necrosis factor and colony-stimulating factors. Blood (1991) 1.21
A recombinant murine granulocyte/macrophage (GM) colony-stimulating factor derived from an inducer T cell line (IH5.5). Functional restriction to GM progenitor cells. J Exp Med (1986) 1.20
IgA nephropathy and Henoch-Schönlein purpura nephritis with anterior uveitis. Nephron (1988) 1.20
T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2. J Immunol (1986) 1.19
Human large granular lymphocytes are potent producers of interleukin-1. Nature (1984) 1.18
Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo. J Immunol (1988) 1.18
Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas. J Natl Cancer Inst (1986) 1.17
Expression of recombinant rabbit IL-8 in Escherichia coli and establishment of the essential involvement of IL-8 in recruiting neutrophils into lipopolysaccharide-induced inflammatory site of rabbit skin. Int Immunol (1993) 1.17
Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine (1993) 1.17
A report of two cases of Werner's syndrome and review of the literature. J Orthop Surg (Hong Kong) (2003) 1.16
Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production. J Exp Med (2001) 1.16
Clinicopathologic features of the flat adenoma. Dis Colon Rectum (1991) 1.15